Share on Google Plus Share on Twitter
  8
Share on Facebook
  47
Share on LinkedIn Share on PInterest
  2
Share on Fark! Share on Reddit Share on StumbleUpon Tell A Friend 57 Shares     
Printer Friendly Page Save As Favorite View Favorites View Article Stats
2 comments

General News

Selling Marked Up Drugs With Made Up Patients--Part 1

Become a Fan
  (71 fans)
By (about the author)     Permalink       (Page 1 of 1 pages)
Related Topic(s): ; ; ; ; ; ; , Add Tags Add to My Group(s)

Must Read 1   Valuable 1  
View Ratings | Rate It

Headlined to H2 1/30/13

opednews.com

by Martha Rosenberg and Evelyn Pringle

It's happened to anyone who's attended an open-mike session at an FDA advisory committee hearing. A queue of "patients" materializes out of nowhere to testify, often in tears, about the crucial need for approval of a drug the public has often not even heard of.   Sometimes the drug has not been approved by the FDA at all, but often it's just not been approved for the use the patients wants--so it's not reimbursable.

"When insurers balk at reimbursing patients for new prescription medications, these groups typically swing into action, rallying sufferers to appear before public and consumer panels, contact lawmakers, and provide media outlets a human face to attach to a cause," writes Melissa Healy of the Los Angeles Times of the artificial grassroots groups, sometimes called Astroturf.

Who are these "patient groups" with Pharma agendas? They include the Depression and Bipolar Support Alliance, which gets half its funding from Pharma and the National Alliance on Mental Illness (NAMI), which received $23 million in just two years from Pharma. Both were investigated by Congress along with the Mental Health America, the National Alliance for Research on Schizophrenia and Depression, Screening for Mental Health Inc, Children and Adults with Attention Deficit/Hyperactivity Disorder, the National Center for Mental Checkups at Columbia University (Teen Screen) and the Child & Adolescent Bipolar Foundation.

In recent years, a front group called Active Minds has also surfaced on college campuses to tap the lucrative college "mental illness" market.   A lot of money is lost, say Pharma internal documents, when kids go to college and go off the meds their parents and teachers insist they take.

Treating poor people who are on government health plans with expensive drugs is also part of Pharma's plan. "For years, the alliance [NAMI] has fought states' legislative efforts to limit doctors' freedom to prescribe drugs, no matter how expensive, to treat mental illness in patients who rely on government health care programs like Medicaid, says the New York Times . "Some of these medicines routinely top the list of the most expensive drugs that states buy for their poorest patients."

How expensive? The prices listed at DrugStore.com in June 2011 for atypical antipsychotics, for 100 middle dose pills were: Abilify $1,644, Geodon $958, Invega $1,789, Risperdal $953, Seroquel $2,000 and Zyprexa $1,680. The prices for antidepressants at a middle dose for 90 pills were: Celexa $346, Cymbalta $440, Effexor $238, Lexapro $313, Paxil $346, Pristiq $418, Prozac $631, Wellbutrin $311 and Zoloft $381.

Prices for 90 or 100 anticonvulsants pills at a middle dose included Depakote $190, Gabitril $595, Lyrica $282, Neurontin $405 and a walloping $895 for Topamax and $1,040 for Lamictal. (According to the American Enterprise Institute, the government wasted $51 million buying Lamictal in 2009 though a generic was available.)



by Martha Rosenberg

The cost for common drug "cocktails" is even worse. If a bipolar child is prescribed a middle dose of the mood stabilizers Topamax and Lamictal, the yearly cost would be $23,220. If Seroquel is added, at a cost of $24,000, along with the ADHD drug Concerta at $7,812, and Neurontin at $4,860, one bipolar child would make Pharma $59,892 a year based on 2011 prices at DrugStore.com. No wonder Pharma wants us, the taxpayers, to pick up the tab.

Of course the Pharma buzz is that pills are cheaper than "talk therapy." But the $24 billion a year the US spends on antidepressants and antipsychotics alone would enable 240,000 psychotherapists to provide 6 million hours of psychotherapy according to one journal article. Nor would the therapists require faux patient groups.

END

 

Martha Rosenberg is an award-winning investigative pubic health reporter who covers the food, drug and gun industries. Her first book, Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health, is distributed by Random (more...)
 

Share on Google Plus Submit to Twitter Add this Page to Facebook! Share on LinkedIn Pin It! Add this Page to Fark! Submit to Reddit Submit to Stumble Upon

The views expressed in this article are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.

Writers Guidelines

Contact Author Contact Editor View Authors' Articles

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

Grassley Investigates Lilly/WebMD link Reported by Washington Post

The Drug Store in Your Tap Water

Are You Sure You're Not Psychotic Asks Shameless Drug Company?

It's the Cymbalta Stupid

MRSA and More. Antibiotics Linked to Obesity and Allergies, Too

Another Poorly Regulated "Derivative"--the Antidepressant Pristiq

Comments

The time limit for entering new comments on this article has expired.

This limit can be removed. Our paid membership program is designed to give you many benefits, such as removing this time limit. To learn more, please click here.

Comments: Expand   Shrink   Hide  
2 people are discussing this page, with 2 comments
To view all comments:
Expand Comments
(Or you can set your preferences to show all comments, always)

This is really good...and sadly true. I'm glad you... by Cheri Roberts on Thursday, Jan 31, 2013 at 8:44:05 AM
Antidepressants destroy the frontal lobes, where c... by Julie Munn on Saturday, Feb 2, 2013 at 5:39:23 AM